(Q35579238)

English

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

scientific article published on 19 April 2011

Statements

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial (English)
François Piette
Joël Belmin
Hélène Vincent
Nicolas Schmidt
Sylvie Pariel
Caroline Marquis
Jean-Pierre Kinet
Alain Moussy

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit